Geode Capital Management’s BioLineRX BLRX Stock Holding History

Geode Capital Management’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,000	Closed	-$8.5K	–	4484
2024 Q4	$8.5K	Hold	1,000	–	–	﹤0.01%	4450
2024 Q3	$21.4K	Hold	1,000	–	–	﹤0.01%	4391
2024 Q2	$22.6K	Hold	1,000	–	–	﹤0.01%	4430
2024 Q1	$44.8K	Hold	1,000	–	–	﹤0.01%	4341
2023 Q4	$62.8K	Buy	1,000 +199	+25%	+$12.3K	﹤0.01%	4300
2023 Q3	$58.3K	Hold	801	–	–	﹤0.01%	4384
2023 Q2	$51.1K	Hold	801	–	–	﹤0.01%	4503
2023 Q1	$28.1K	Hold	801	–	–	﹤0.01%	4642
2022 Q4	$18K	Hold	801	–	–	﹤0.01%	4780
2022 Q3	$29K	Hold	801	–	–	﹤0.01%	4850
2022 Q2	$40K	Hold	801	–	–	﹤0.01%	4821
2022 Q1	$54K	Hold	801	–	–	﹤0.01%	4788
2021 Q4	$65K	Hold	801	–	–	﹤0.01%	4811
2021 Q3	$87K	Buy	801 +544	+212%	+$64.5K	﹤0.01%	4703
2021 Q2	$28K	Hold	257	–	–	﹤0.01%	4698
2021 Q1	$28K	Hold	257	–	–	﹤0.01%	4437
2020 Q4	$25K	Buy	+257	New	+$22.5K	﹤0.01%	4232
2019 Q3	–	Sell	-144	Closed	-$31K	–	4195
2019 Q2	$31K	Buy	144 +48	+50%	+$10.8K	﹤0.01%	4125
2019 Q1	$24K	Hold	96	–	–	﹤0.01%	4081
2018 Q4	$25K	Hold	96	–	–	﹤0.01%	4071
2018 Q3	$61K	Hold	96	–	–	﹤0.01%	4006
2018 Q2	$52K	Buy	96 +54	+129%	+$28.7K	﹤0.01%	3973
2018 Q1	$22K	Hold	42	–	–	﹤0.01%	4015
2017 Q4	$27K	Hold	42	–	–	﹤0.01%	3983
2017 Q3	$28K	Hold	42	–	–	﹤0.01%	3996
2017 Q2	$21K	Hold	42	–	–	﹤0.01%	4039
2017 Q1	$24K	Buy	+42	New	+$27K	﹤0.01%	4029

Other funds holding BLRX

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management's BLRX Position: Q1 2025 in Review

Geode Capital Management sold out of BioLineRX (BLRX) in Q1 2025, closing a stake of 1,000 shares — an estimated $8.5K sold.

Geode Capital Management first reported a position in BLRX in Q1 2017 and held it in 27 quarters. The position peaked at $87K in Q3 2021. 12 funds tracked by Wall St. Rank hold BLRX as of Q1 2025.

Geode Capital Management reported no remaining BioLineRX position as of Q1 2025 after selling out during the quarter.
Geode Capital Management sold 1,000 BioLineRX shares in Q1 2025, an estimated $8.5K.
Geode Capital Management first reported a position in BioLineRX in Q1 2017 and held it in 27 quarters.
Geode Capital Management's BioLineRX position peaked at $87K in Q3 2021.
12 funds tracked by Wall St. Rank held BioLineRX as of Q1 2025.

Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.